Medical Affairs and Country Brand Lead
Since January 2013
Since January 2010
Consultancy company (CRO) with special knowledge within life science and the pharmaceutical and biotech industry - interim and specific assignments. Pharma-Business offers assistance within the following areas: ▪ Medical Affairs Strategy and Medical Affairs activities ▪ Medical Marketing ▪ Development of new medicine ▪ Compliance - medical and legal approval ▪ Identification and evaluation of new products and therapy areas ▪ Clinical Development – Clinical Trials ▪ Business Strategy ▪ Brand Management ▪ Promotion Material ▪ Competitor Intelligence ▪ Pharmacovigilance and Safety
January 2013 --- January 2013
Responsible for establishing Medical Affairs in Denmark. Main focus on the launch of a new innovative medicine for ADHD - Elvanse.
January 2010 --- January 2012
Responsible for global safety on haemophilia products already on the market (NovoSeven) and new within development.
Senior Vice President Global R&D and Competitive Intelligence
January 2005 --- January 2010
Reference to the Executive Vice President - Board of Management. Responsible for various strategic initiative and a Competitor Intelligence Function with the focus to expend the business and strengthen competitiveness. Strategic projects included: ▪ Corporate Strategy ▪ R&D strategy ▪ Competitor Strategy ▪ Risk Management ▪ Risk management ▪ Acquisition Strategy ▪ Innovation Management
Senior Vice President Global Clinical Development, Biometrics, Medical Writing & Pharmacovigillance
January 2001 --- January 2005
Reference to Executive Vice President - Board of Management. Establishment and responsbilbe for Global Clinical Development, Biometrics, Medical Writing and Pharmacovigillance. People management, budget and plans. World’s largest trials on allergy vaccination, registration of the world’s first innovative grass allergy vaccine and launch of Grazax®. Pipeline formation, strategic partnership and listing of company.
Sales - and Marketing Manager
January 2000 --- January 2001
Profit and loss responsibility for Schering-Plough Nordic Biotech. Development of marketing plan, promotion initiatives, clinical trial activities, pharmacoeconomic initiatives and communication with customers, payers, authorities and key opinion leaders. Establishment of CRM system and engaged in sales calls.
International Clinical Manager
January 1999 --- January 2000
Clinical phase III trial management on large multi-centre trial. Hands-on experience on activities such as writing of protocol, development of case record forms (CRF), execution of study, statistical analysis plan, opinion leader contact, handling of external safety board and communication with authorities. Collaboration with regulatory, marketing, data management, biometrics, affiliates etc.
Manager Core Products
January 1998 --- January 1999
Management of national and international team working with strategic core products. Development of new indications on core products based on clinical development plans to expand the market. Execution of clinical trials (phase III). Evaluation of in-licensing opportunities
International Medical Advisor
January 1995 --- January 1998
Establishment of new Medical Affairs Unit in Strategic Marketing. Day-today marketing activities for existing products and pre-launch/launch activities for new products. Medical-marketing plan, product portfolio management within Women’s Healthcare (incl. in-licensing opportunities), new visual identity and communication strategy. Pre-launch and launch activities such as product positioning, value proposition, key messages, pricing, key claims, competitor differentiation, phase IV-plans, training material, education of affiliates/doctors, symposia programs, publication planning, brand management, key opinion leader management. Risk management and crises handling due to safety issue. Meetings with regulatory authorities.
International Medical Advisor
January 1992 --- January 1995
Medical Affairs in Global marketing. Day-to-day marketing activities to support existing product portfolio, development and implementation of lifecycle management (revitalization of anti-psychotic brands). Launch of new products within CNS field – antidepressants Cipramil®. Medical-marketing plans, product positioning, value proposition, key claims, brand differentiation, pricing, visual identity, medical communication strategy, phase IV trials, advisory boards, publication management, key opinion leader management, education and training, chairman of task-force groups, valuation of new in-licensing opportunities etc.
January 1991 --- January 1992
Responsible (incl. budget) for the largest education project within the Wound & Skincare Division. Successful international launch of this unique educational material - in several countries the material constitutes a mandatory part of obtaining specialization to e.g. dermatologists. Build up a global advisory board instrumental for the endorsement and acceptance of moist wound healing concept among key opinion leaders, nurses and others engaged in handling of wounds. Project management, chairman of advisory board, editor on education program, publications and presentations at congresses, clinical development plans & clinical trials execution.
January 1989 --- January 1991
Innovation and Business Developments, Growth Strategy Planning in from DTU Executive School of Business in 2012
Executive MBA in Strategy and Business from Executive MBA - Scandinavian International Management Institute (SIMI) l Copenhagen Business School in 2007
Medical Doctor in Medical Doctor from Medical Doctor (MD) - University of Copenhagen in 1989
in Eduction in Board Governance from Educated Board Member - Board Governance in 0
in from Executive Coach - The Leadership Company in 0